Allergen Research Changes Its Name to Aimmune Therapeutics

“BrightSource is a complex environment for a variety of reasons: innovative technology, differing objectives among investors, global operations, not quite commercial status – among others. Our FLG partner, Doug Lehrmann, stepped in initially to our CFO slot under a “we need you now” scenario. He quickly sized up the situation, became a respected and trusted member of our Executive Committee and provided quick actions along a variety of fronts that streamlined operations and stabilized the Company. I then asked Doug to move to a newly created COO slot so that I could promote a high potential internal resource to CFO; Doug made the move seamlessly and was invaluable to me in taking on specific tasks that crossed multiple functional responsibilities. BrightSource is a now on path that we believe best positions it for success. Without Doug’s help, I’m not sure we would have the opportunity – for sure full of challenges, but a real chance – that we now have in front of us. Thanks for helping getting Doug to us, and we wish him and FLG much success in the future.”